General Information of Drug (ID: DM0092Q)

Drug Name
VAL-201
Indication
Disease Entry ICD 11 Status REF
Solid tumour/cancer 2A00-2F9Z Phase 1/2 [1]
Cross-matching ID
PubChem CID
71516519
TTD ID
D0M3QT

References

1 ClinicalTrials.gov (NCT02280317) Dose Finding Safety Study of VAL201 in Cancer Patients. U.S. National Institutes of Health.